BioStem Technologies

BioStem Technologies is excited to exhibit at The Western Foot & Ankle Conference, one of the premier events bringing together podiatrists, surgeons, wound care specialists, and healthcare professionals dedicated to advancing patient care. https://hubs.ly/Q04jy6-C0

Stop by our booth to learn how our innovative amniotic tissue allografts help clinicians support wound care through our proprietary processing methods.

Whether you're looking to improve outcomes, reduce treatment times, or explore the latest advancements in regenerative wound care, we’d love to connect.

See you at The Western!

"What inspires you most about working in wound care? Share your story in the comments below."

June is Wound Healing Awareness Month.

Every wound tells a story—and behind every successful healing journey is a team of dedicated healthcare professionals committed to helping patients regain their health, mobility, and quality of life.

This month, we recognize the clinicians, caregivers, researchers, and advocates who work tirelessly to advance wound care and improve patient outcomes. We also honor the patients whose resilience inspires us every day.

At BioStem, we remain committed to supporting the wound care community through innovation, science, and our relentless pursuit of healing.

Together, we can raise awareness about the importance of early intervention, advanced treatment options, and evidence-based care that helps patients return to living their lives.

Join us throughout June as we celebrate Wound Healing Awareness Month and the incredible people making a difference in wound care every day.

WOCNext 2026 wraps up tomorrow.

It's great to connect with so many passionate wound care professionals, clinicians, researchers, and industry leaders who are all committed to advancing patient outcomes and shaping the future of wound care.

A huge thank you to everyone who has stopped by our booth, shared their experiences, asked questions, and learned more about BioStem's commitment to innovation in our relentless pursuit of healing.

Events like WOCNext continue to highlight the importance of collaboration, education, and evidence-based solutions in advancing wound, ostomy, and continence care. We are grateful to be part of a community that is dedicated to improving the lives of patients every day.

Thank you to the WOCN Society and the WOCNext team for hosting another outstanding event. We look forward to continuing the conversations and partnerships that began this week.

This Memorial Day, we pause to honor and remember the brave men and women who made the ultimate sacrifice for our freedom. Their courage, selflessness, and unwavering dedication to our country will never be forgotten.

To all who gave everything for this nation, and to the families who carry their legacy forward, we thank you.

BioStem Technologies has announced a $2.5 million private placement financing with its first institutional investor — another major milestone as the company continues strengthening its balance sheet and advancing toward a Nasdaq uplisting.

“This transaction marks continued progress in the ex*****on of our capital markets strategy,” said Chairman & CEO Jason Matuszewski.

Combined with the company’s previously announced debt retirement, this latest move highlights BioStem’s continued focus on building a stronger financial foundation to support long-term expansion in the regenerative medicine space.

Read the full release: https://hubs.ly/Q04hCBSS0

BioStem Technologies continues to strengthen its position as a leader in regenerative medicine and placental-derived biologics.

We are proud to announce that the USPTO has issued Notices of Allowance for four new U.S. design patent applications related to our fenestrated human placental allograft technologies, while the European Patent Office has also granted a new patent covering sterile human placental allografts and proprietary manufacturing methods for growth factor-rich placental tissue allografts.

These innovations are designed to support improved fluid management, conformability, tissue integration, and preservation of the natural biological characteristics of placental tissue — helping advance next-generation solutions for wound care, surgical, and regenerative applications.

With more than 70 patents in our growing global portfolio, BioStem remains committed to driving innovation that helps clinicians deliver better outcomes for patients.

“This milestone reflects our continued focus on protecting the innovation behind our advanced perinatal tissue allograft technologies.”
— Jason Matuszewski, CEO, BioStem Technologies

Click here for full release: https://hubs.ly/Q04hjRH_0

🚀 We’re Growing at BioStem Technologies — Join The Stem! 🚀

BioStem continues to expand, and we’re looking for passionate, driven professionals to join our mission of advancing regenerative medicine and wound care innovation.

Current Openings Include:

🔹 Sales Representatives
🔹 Product Manager
🔹 Market Access Director

At BioStem, we’re not just building a company — we’re building the future of regenerative medicine. If you’re ready to make an impact with a rapidly growing biotech leader, we’d love to hear from you.

📍 Explore opportunities and apply today: https://hubs.ly/Q04hj0Yy0